AVR 0.00% $12.19 anteris technologies ltd

Interesting, mesoblast just announced their phase 3 trial for...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,887 Posts.
    lightbulb Created with Sketch. 248
    Interesting, mesoblast just announced their phase 3 trial for back pain. Only 300 patients in a randomised. Given we have a device and not a drug, our trial should have fewer patients.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.